News Search Results
Apr 03, 2024, 08:00 ET Latvian pharmaceutical manufacturing company Grindeks opens new subsidiaries worldwide
dermatology, cardiology, and active pharmaceutical ingredients. The subsidiary Kalceks specializes in medications for the hospital segment and ophthalmology. All products are manufactured according to high global safety and quality standards. The Grindeks group employs more than 1,380 industry professionals.
More news about: Grindeks
Apr 03, 2024, 03:00 ET Latvian pharmaceutical manufacturing company Grindeks opens new subsidiaries worldwide
dermatology, cardiology, and active pharmaceutical ingredients. The subsidiary Kalceks specializes in medications for the hospital segment and ophthalmology. All products are manufactured according to high global safety and quality standards. The Grindeks group employs more than 1,380 industry professionals.
More news about: Grindeks
Apr 02, 2024, 13:15 ET Kyowa Kirin Announces Acceptance of Abstract for Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
tivozanib eye drop for neovascular age-related macular degeneration (nAMD), will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held in Seattle, Washington from May 5-9, 2024.
More news about: Kyowa Kirin
Apr 02, 2024, 07:00 ET Priovant Therapeutics Announces Positive Phase 2 NEPTUNE Study Results for Brepocitinib in Non-Infectious Uveitis (NIU), Showing Strongest Efficacy Data in NIU Observed to Date
irreversible blindness," said Quan Dong Nguyen, MD, MSc, FARVO, FASRS, NEPTUNE investigator and Professor of Ophthalmology at the Byers Eye Institute, and Professor of Medicine and Pediatrics at Stanford University School of Medicine. "Current
More news about: Priovant Therapeutics
Apr 02, 2024, 01:00 ET Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, and HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today jointly announce
More news about: Innovent Biologics
Apr 01, 2024, 15:02 ET Avirmax Biopharma Inc. to Present at the 2024 ARVO Annual Meeting in Seattle
Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Seattle between May 5th and 9th, 2024. ARVO is the largest international society dedicated to ophthalmology and vision-related topics.
More news about: Avirmax
Apr 01, 2024, 10:10 ET THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) IS NOW ACCEPTING APPLICATIONS FOR TWO AACS CERTIFIED COSMETIC SURGERY FELLOWSHIP TRAINING PROGRAMS
practitioners from a diverse array of medical specialties, including dermatology, oral & maxillofacial surgery, otolaryngology, general surgery, ophthalmology, and plastic/reconstructive surgery. AACS is composed of over 1,600 members who pursue educational and training opportunities in cosmetic surgery
More news about: American Academy of Cosmetic Surgery (AACS)
Apr 01, 2024, 08:00 ET ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma
Arboretum Ventures and Falcon Vision, an ophthalmology investment platform supported by
More news about: ViaLase, Inc.
Apr 01, 2024, 06:59 ET Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
2. American Academy of Ophthalmology. Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern. American Academy of Ophthalmology. 2020;1-29.
More news about: Viatris Inc.
Mar 28, 2024, 09:00 ET Beyeonics Vision Appoints A. Burton Tripathi, PhD, as CEO
strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.
More news about: Beyeonics
Mar 28, 2024, 09:00 ET ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024
Euan S. Thomson, Ph.D., President of Ophthalmology and Head of the Digital Business Unit for ZEISS Medical Technology. "We're consistently innovating to deliver on our vision for the future of ophthalmology through fully connected, digital workflows that are setting new standards
More news about: Carl Zeiss Meditec AG
Mar 28, 2024, 09:00 ET ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024
Euan S. Thomson, Ph.D., President of Ophthalmology and Head of the Digital Business Unit for ZEISS Medical Technology. "We're consistently innovating to deliver on our vision for the future of ophthalmology through fully connected, digital workflows that are setting new standards
More news about: Carl Zeiss Meditec AG
Mar 28, 2024, 06:08 ET Aesthetic Management Partners Announces Partnership with Croma-pharma To Distribute Plant-Based Exosome Technology to Europe
Australia/New Zealand. It also operates as a contract manufacturer in orthopedics and ophthalmology. For more information, please visit
More news about: Aesthetic Management Partners
Mar 27, 2024, 06:51 ET Global Mobile Health Vehicle Market to Reach $383.3 Million, by 2030 at 6.6% CAGR: Coherent Market Insights
by mobile health vehicles include intensive care, mental health, dental care, phlebotomy, diagnostics (infectious disease testing and others), ophthalmology, and others. This diverse range of services ensures that patients can receive specialized medical attention even in remote areas where such services
More news about: Coherent Market Insights
Mar 27, 2024, 06:15 ET Increasing Risk of Eye Infections from Contact Lens Use to Surge Ophthalmology Packaging Market at a CAGR of 5.4% Through 2034: Future Market Insights
to eliminate microbial growth for increased safety and shelf life. Key Takeaways from the Global Ophthalmology Packaging Market The global ophthalmology packaging market is expected to reach US$ 3,063.9 million by 2034. By 2034, the global market
More news about: Future Market Insights
Mar 26, 2024, 20:00 ET Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed with IBI310 (anti-CTLA-4 monoclonal antibody) in combination
More news about: Innovent Biologics
Mar 26, 2024, 16:01 ET Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 Guidance
segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; and gastrointestinal products. Its Specialty Generics
More news about: Mallinckrodt plc
Mar 26, 2024, 07:00 ET Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa
scientific meetings in the coming months, beginning with a presentation at the Annual Scientific Meeting of the Association for Research in Vision and Ophthalmology on May 6, 2024, in Seattle, Washington, by Allen Ho,
More news about: Nanoscope Therapeutics
Mar 26, 2024, 07:00 ET Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa
scientific meetings in the coming months, beginning with a presentation at the Annual Scientific Meeting of the Association for Research in Vision and Ophthalmology on May 6, 2024, in Seattle, Washington, by Allen Ho,
More news about: Nanoscope Therapeutics
Mar 25, 2024, 13:09 ET HCSC Offers Members New Provider Scores in Search
MedicineGastroenterology Internal MedicineNephrology Neurology Obstetrics and Gynecology Ophthalmology Orthopedic Surgery PediatricsPulmonary RheumatologyUrology Vascular SurgeryGeneral
More news about: Health Care Service Corporation
Mar 22, 2024, 12:18 ET Pharmaceuticals Market In Germany size is set to grow by USD 21.44 bn from 2023-2027, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors- Technavio
Analysis In the German pharmaceuticals market, several key players are making significant strides. Bausch + Lomb, for instance, is focusing on ophthalmology with products like Globican 2018, which provides global cancer incidence and mortality data. In oncology, Empagliflozin from Boehringer Ingelheim
More news about: Technavio
Mar 21, 2024, 12:02 ET Landmark Non-inferiority Clinical Trial Demonstrates Nanodropper's Positive Impact on Glaucoma Treatment
A new study published in Ophthalmology demonstrated no clinically significant difference in IOP with microdrops with the Nanodropper® Adaptor versus conventional eyedrops of the glaucoma treatment timolol maleate 0.5%. ROCHESTER,
More news about: Nanodropper
Mar 21, 2024, 10:42 ET OcuMension (01477.HK) Invests Over RMB 123.8 Million in Research, Technology and Self-development Progress in Tandem, Main Product Sales Show Comprehensive Growth
and efficient medical services. Chasing light and encountering, forging ahead. The development of innovative drugs in the field of Chinese ophthalmology is arduous but promising. With the continuous improvement in market recognition of the company's products, OcuMension will continue to uphold the
More news about: OcuMension
Mar 21, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update
urologic diseases for over 50 years. HanAll has also expanded its focus to immunology, oncology, neurology, and ophthalmology to discover and develop innovative medicines for patients with diseases for which there are no effective treatments. Its lead pipeline asset, HL161
More news about: HanAll Biopharma
Mar 20, 2024, 22:30 ET 百萬里程譜新篇 | ICL晶體植入量全球突破300萬
2016;123:1036-1042 © 2016 by the American Academy of Ophthalmology） 1 EVO ICL accounts for approximately 2.5 million of the 3 million total ICLs sold.2 Ophthalmology 2016;123:1036-1042 © 2016 by the American Academy of Ophthalmology. 關於STAAR Surgical 40多年來，STAAR
More news about: STAAR Surgical